ST3GAL4, ST3 beta-galactoside alpha-2,3-sialyltransferase 4, 6484
N. diseases: 115; N. variants: 26
Source: ALL
Disease | Type | Disease Class | Semantic Type | N. genes d | N. SNPs d | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
disease | Neoplasms | Neoplastic Process | 325 | 30 | 0.300 | None | 1.000 | 1 | 2006 | 2006 | |||||
|
group | Infections | Disease or Syndrome | 237 | 12 | 0.300 | None | 1.000 | 1 | 2017 | 2017 | |||||
|
disease | Neoplasms; Stomatognathic Diseases | Neoplastic Process | 91 | 0.300 | None | 1.000 | 1 | 2006 | 2006 | ||||||
|
group | Neoplasms; Stomatognathic Diseases | Neoplastic Process | 116 | 3 | 0.300 | None | 1.000 | 1 | 2006 | 2006 | |||||
|
group | Nutritional and Metabolic Diseases; Endocrine System Diseases | Disease or Syndrome | 2803 | 824 | 0.100 | None | 1.000 | 43 | 2008 | 2020 | |||||
|
disease | Endocrine System Diseases | Disease or Syndrome | 2359 | 710 | 0.100 | None | 1.000 | 33 | 2008 | 2019 | |||||
|
disease | Nutritional and Metabolic Diseases | Disease or Syndrome | 1098 | 108 | 0.100 | None | 1.000 | 23 | 2012 | 2020 | |||||
|
disease | Nutritional and Metabolic Diseases; Endocrine System Diseases | Disease or Syndrome | 3134 | 2672 | 0.100 | None | 1.000 | 21 | 2014 | 2019 | |||||
|
disease | Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases | Disease or Syndrome | 1189 | 238 | 0.100 | None | 1.000 | 10 | 2014 | 2019 | |||||
|
phenotype | Laboratory Procedure | 483 | 1142 | 0.100 | None | 1.000 | 9 | 7 | 2010 | 2019 | |||||
|
phenotype | Laboratory Procedure | 486 | 1243 | 0.100 | None | 1.000 | 7 | 6 | 2010 | 2018 | |||||
|
phenotype | Laboratory Procedure | 42 | 79 | 0.100 | None | 1.000 | 2 | 3 | 2011 | 2018 | |||||
|
phenotype | Laboratory Procedure | 269 | 555 | 0.100 | None | 1.000 | 2 | 1 | 2010 | 2013 | |||||
|
phenotype | Laboratory Procedure | 223 | 371 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||
|
phenotype | Laboratory Procedure | 2 | 6 | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||
|
phenotype | Laboratory Procedure | 545 | 1440 | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||
|
phenotype | Organism Attribute | 130 | 312 | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | |||||
|
phenotype | Laboratory Procedure | 135 | 624 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||
|
phenotype | Laboratory Procedure | 265 | 457 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||
|
phenotype | Organism Attribute | 1903 | 3972 | 0.100 | None | 1.000 | 1 | 2 | 2019 | 2019 | |||||
|
disease | Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms | Disease or Syndrome | 2 | 1 | 0.100 | None | 1.000 | 1 | 1 | 2008 | 2008 | ||||
|
phenotype | Laboratory Procedure | 15 | 42 | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||
|
phenotype | Laboratory Procedure | 1156 | 2575 | 0.100 | None | 1.000 | 1 | 4 | 2018 | 2018 | |||||
|
phenotype | Laboratory Procedure | 134 | 200 | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||
|
disease | Cardiovascular Diseases | Disease or Syndrome | 1708 | 1577 | 0.100 | None | 1.000 | 1 | 2 | 2018 | 2018 |